Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 9 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 10 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 19 most recent Form 4 transactions.
| XXITM |
| 197,600 |
| $5.00 |
| $988K |
| +10.4% |
| Open the original filing on SEC.gov |
| Apr 23 | ACRS | Aclaris Therapeutics, Inc. | SSELL | 300,000 | $4.53 | $1.4M | -2.1% | Open the original filing on SEC.gov |
| Dec 4, 2025 | ADVM | Adverum Biotechnologies,… | SSELL | 524,560 | $4.19 | $2.2M | -21.1% | Open the original filing on SEC.gov |
| Dec 3, 2025 | ADVM | Adverum Biotechnologies,… | SSELL | 222,925 | $4.17 | $929.6K | -8.4% | Open the original filing on SEC.gov |
| Dec 2, 2025 | ADVM | Adverum Biotechnologies,… | SSELL | 51,961 | $4.20 | $218.2K | -1.9% | Open the original filing on SEC.gov |
| Dec 1, 2025 | ADVM | Adverum Biotechnologies,… | SSELL | 300,000 | $4.20 | $1.3M | -9.8% | Open the original filing on SEC.gov |
| Oct 3, 2025 | ASTC | ASTROTECH Corp | SSELL | 9,166 | $5.83 | $53.4K | -100.0% | Open the original filing on SEC.gov |
| Oct 3, 2025 | ASTC | ASTROTECH Corp | SSELL | 220,410 | $7.13 | $1.6M | -100.0% | Open the original filing on SEC.gov |
| May 30, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 7,000 | $1.03 | $7.2K | -0.2% | Open the original filing on SEC.gov |
| May 30, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 425,000 | $1.01 | $429.3K | -11.7% | Open the original filing on SEC.gov |
| May 28, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 100,000 | $1.16 | $116K | -2.7% | Open the original filing on SEC.gov |
| May 28, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 2M | $1.16 | $2.3M | -34.8% | Open the original filing on SEC.gov |
| May 28, 2025 | ANTX | AN2 Therapeutics, Inc. | SSELL | 200,000 | $1.09 | $218K | -6.2% | Open the original filing on SEC.gov |
| Apr 23, 2025 | ADVM | Adverum Biotechnologies,… | PBUY | 50,000 | $2.98 | $149K | +35.3% | Open the original filing on SEC.gov |
| Apr 22, 2025 | ADVM | Adverum Biotechnologies,… | PBUY | 300,000 | $3.00 | $900K | +10.9% | Open the original filing on SEC.gov |
| Mar 27, 2025 | ADVM | Adverum Biotechnologies,… | PBUY↺ | 16,593 | $5.19 | $86.1K | +13.3% | Open the original filing on SEC.gov |
| Mar 26, 2025 | ADVM | Adverum Biotechnologies,… | PBUY↺ | 20,407 | $5.04 | $102.8K | +19.5% | Open the original filing on SEC.gov |